Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

NCT04440618 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT04440618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04440618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 30, 2020
Completion date
June 30, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea-hypopnea, oropharyngeal cancer